Free Cash Flow

CytRx Corporation (CYTR)

$ 3.12
0.28 (+9.86%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.300.100.100.200.100.250.330.440.590.791.051.401.87
Revenue (%)
Operating Cash Flow -23.75-40.56-47.58-49.85-27.20-10.87-5.72-6.14-115.28-153.70-204.93-273.25-364.33
Operating Cash Flow (%)
Capital Expenditure -0.04-0.96-0.33-1.02-0.13-0.01-0.02-0.03-1.45-1.94-2.59-3.45-4.60
Capital Expenditure (%)
Free Cash Flow -23.79-41.51-47.91-50.87-27.33-10.88-5.74-6.17-116.73-155.64-207.52-276.69-368.93

FCF Unlevered from cash flow statement